We've raised $150,000 thus far from 214 investors. $100K and less than 60 days to go at a discounted valuation.
Invest in an early startup that is tackling the largest cause of infant death in the world.
We are more than halfway through our campaign with less than 60 days left and $100K remaining at our special discounted valuation.
Invest in Amnion Life, a startup which can change the field of neonatology and future of preterm infant care and tackle the leading cause of infant death globally This week, Japan's patent office found all claims in Japan's Amniobed application as novel and non-obvious and we've been granted the Japanese patent. Together with two US patents and the Chinese patent granted earlier, we are now the leader in the field of the artificial womb and at the forefront of neonatal care in the 21st century. Preterm birth is the #1 cause of infant mortality in the United States. Per WHO, it is the leading cause of children's death below the age of 5 years, beating any infectious disease. Help us eliminate this greatest cause of pain and suffering for infants and mothers across America and the World.
With previous investments, we:
We have room for $100,000 investments using the significant discount to $7.5M cap. This is a limited discount and your opportunity to invest in a company at a very early stage. The Problem:
Amnion Life has the potential to:
Be a part of this journey and through your investment, help us change the world for the tiniest and most vulnerable human beings on earth. Don't forget that Wefunder allows investments via IRA funds.
Privacy: We won’t share your data, or post to your wall, without your permission.
Already have a Wefunder account? Login
Don't have a Wefunder account? Signup